Peter J. Bossuyt

Peter J. Bossuyt

Bonheiden, VLG, Belgium

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 138 publications

International consensus on the use of intestinal ultrasound in inflammatory bowel disease trials.

International consensus on the use of intestinal ultrasound in inflammatory bowel disease trials.

Journal: Journal of Crohn's & colitis

Published: September 19, 2025

The Effect of Dose Intensification After Secondary Loss of Response to Ustekinumab in Crohn's Disease: Results of the REScUE Study.

The Effect of Dose Intensification After Secondary Loss of Response to Ustekinumab in Crohn's Disease: Results of the REScUE Study.

Journal: Gastroenterology

Published: September 13, 2025

Results of the 9th Scientific Workshop of the European Crohn's and Colitis Organisation (ECCO): Artificial Intelligence in Endoscopy, Radiology and Histology in IBD Diagnostics.

Results of the 9th Scientific Workshop of the European Crohn's and Colitis Organisation (ECCO): Artificial Intelligence in Endoscopy, Radiology and Histology in IBD Diagnostics.

Journal: Journal of Crohn's & colitis

Published: August 12, 2025

Results of the Ninth Scientific Workshop of the European Crohn's and Colitis Organisation (ECCO): artificial intelligence in IBD: regulatory and methodological considerations.

Results of the Ninth Scientific Workshop of the European Crohn's and Colitis Organisation (ECCO): artificial intelligence in IBD: regulatory and methodological considerations.

Journal: Journal of Crohn's & colitis

Published: August 12, 2025

Results of the Ninth Scientific Workshop of the European Crohn's and Colitis Organisation (ECCO): Artificial Intelligence in medical management and precision medicine.

Results of the Ninth Scientific Workshop of the European Crohn's and Colitis Organisation (ECCO): Artificial Intelligence in medical management and precision medicine.

Journal: Journal of Crohn's & colitis

Published: August 12, 2025

Results of the Ninth Scientific Workshop of the European Crohn's and Colitis Organisation (ECCO): Artificial intelligence in IBD surgery: opportunities and limitations.

Results of the Ninth Scientific Workshop of the European Crohn's and Colitis Organisation (ECCO): Artificial intelligence in IBD surgery: opportunities and limitations.

Journal: Journal of Crohn's & colitis

Published: August 12, 2025

Results of the 9th Scientific Workshop of the European Crohn's and Colitis Organisation (ECCO): Artificial Intelligence in medical management and precision medicine.

Results of the 9th Scientific Workshop of the European Crohn's and Colitis Organisation (ECCO): Artificial Intelligence in medical management and precision medicine.

Journal: Journal of Crohn's & colitis

Published: August 12, 2025

Results of the Ninth Scientific Workshop of the European Crohn's and Colitis Organisation (ECCO): artificial intelligence in endoscopy, radiology, and histology in inflammatory bowel disease diagnostics.

Results of the Ninth Scientific Workshop of the European Crohn's and Colitis Organisation (ECCO): artificial intelligence in endoscopy, radiology, and histology in inflammatory bowel disease diagnostics.

Journal: Journal of Crohn's & colitis

Published: August 12, 2025

Results of the Ninth Scientific Workshop of the European Crohn's and Colitis Organisation (ECCO): artificial intelligence in IBD surgery-opportunities and limitations.

Results of the Ninth Scientific Workshop of the European Crohn's and Colitis Organisation (ECCO): artificial intelligence in IBD surgery-opportunities and limitations.

Journal: Journal of Crohn's & colitis

Published: August 12, 2025

Impact of mirikizumab treatment on fatigue in patients with moderately to severely active Crohn's disease: results from the phase 3 VIVID-1 study.

Impact of mirikizumab treatment on fatigue in patients with moderately to severely active Crohn's disease: results from the phase 3 VIVID-1 study.

Journal: Journal of Crohn's & colitis

Published: June 10, 2025

Higher Vedolizumab Clearance Associates with Poor Therapeutic Outcomes during Intravenous Vedolizumab Maintenance Therapy in Crohn's Disease.

Higher Vedolizumab Clearance Associates with Poor Therapeutic Outcomes during Intravenous Vedolizumab Maintenance Therapy in Crohn's Disease.

Journal: Inflammatory bowel diseases

Published: June 04, 2025

Inflammation Is a Large Dataset of Heartbeats, Groceries, Night Rest, and More.

Inflammation Is a Large Dataset of Heartbeats, Groceries, Night Rest, and More.

Journal: Gastroenterology

Published: May 18, 2025

Showing 1-12 of 138

Last Updated: 09/26/2026